ANTIHYPERTENSIVE AGENT

Brand Owner (click to sort) Address Description
ANITEN UPJOHN COMPANY, THE Kalamazoo MI ANTIHYPERTENSIVE AGENT;
BENTENSIN BRISTOL-MYERS COMPANY New York NY ANTIHYPERTENSIVE AGENT;
BRISTENSIN BRISTOL-MYERS COMPANY New York NY ANTIHYPERTENSIVE AGENT;
LINADOX UPJOHN COMPANY, THE Kalamazoo MI ANTIHYPERTENSIVE AGENT;
LUDRAL AMERICAN HOME PRODUCTS CORPORATION New York NY ANTIHYPERTENSIVE AGENT;
MODOX UPJOHN COMPANY, THE Kalamazoo MI ANTIHYPERTENSIVE AGENT;
MONITAN AMERICAN HOME PRODUCTS CORPORATION New York NY ANTIHYPERTENSIVE AGENT;
PRENSOR SMITH KLINE & FRENCH LABORATORIES 1530 SPRING GARDEN ST. PHILADELPHIA PA ANTIHYPERTENSIVE AGENT;
RAUDIXIN E.R. SQUIBB & SONS, INC. LAWRENCEVILLE-PRINCETON ROAD PRINCETON NJ 08540 ANTIHYPERTENSIVE AGENT;
THE "VASODILATING BETA BLOCKER" SANDOZ PHARMACEUTICALS CORPORATION 59 ROUTE 10 EAST HANOVER NJ 07936 ANTIHYPERTENSIVE AGENT;THE VASODILATING BETA BLOCKER;
WYDORA AMERICAN HOME PRODUCTS CORPORATION New York NY ANTIHYPERTENSIVE AGENT;
WYTENSIN AMERICAN HOME PRODUCTS CORPORATION New York NY ANTIHYPERTENSIVE AGENT;WHYTENSION;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods of using a genetic polymorphic variation in the human beta-1 adrenergic receptor gene as a drug response marker are presented. Determining the presence or absence of the A145G genetic variation in the human beta-1 adrenergic receptor gene is useful in predicting an individual's relative response to different antihypertensive drugs; optimizing antihypertensive treatment for an individual; selecting candidate human subjects for participation in clinical trials involving antihypertensive drugs; and, predicting the relative responses among a plurality of individuals to an antihypertensive drug.